Review
Open access
Sep 2026
The global landscape of pediatric monoclonal antibody (mAb) clinical trials: an analysis of ClinicalTrials.gov
The findings suggest that mAb clinical trials permitting pediatric enrollment are geographically concentrated, disease-selective, and insufficiently transparent, which can inform policy and investment decisions to ensure equitable and transparent research on mAbs for pediatric populations.
Agrata Sharma, Sanjana Mukherjee, Sharonann Lynch
· Frontiers in Pediatrics · 0 citations